SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-019134
Filing Date
2024-04-10
Accepted
2024-04-10 16:50:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20018910x3_defa14a.htm DEFA14A 12507
2 ny20018910x3_na1.jpg GRAPHIC 303242
3 ny20018910x3_na2.jpg GRAPHIC 437890
  Complete submission text file 0001140361-24-019134.txt   1034117
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-29889 | Film No.: 24836405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)